Microsoft Excel LibreOffice Calc

Johnson & Johnson (JNJ)


Liquidity Analysis

Difficulty: Beginner


Ratios (Summary)

Johnson & Johnson, liquidity ratios

Microsoft Excel LibreOffice Calc
Dec 30, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 28, 2014
Current ratio 1.47 1.41 2.47 2.17 2.36
Quick ratio 1.08 1.04 2.04 1.77 1.76
Cash ratio 0.63 0.60 1.59 1.38 1.32

Based on: 10-K (filing date: 2019-02-20), 10-K (filing date: 2018-02-21), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-24).

Ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Johnson & Johnson’s current ratio deteriorated from 2016 to 2017 but then slightly improved from 2017 to 2018.
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Johnson & Johnson’s quick ratio deteriorated from 2016 to 2017 but then slightly improved from 2017 to 2018.
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Johnson & Johnson’s cash ratio deteriorated from 2016 to 2017 but then slightly improved from 2017 to 2018.

Current Ratio

Johnson & Johnson, current ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 30, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 28, 2014
Selected Financial Data (USD $ in millions)
Current assets 46,033  43,088  65,032  60,210  59,311 
Current liabilities 31,230  30,537  26,287  27,747  25,085 
Ratio
Current ratio1 1.47 1.41 2.47 2.17 2.36
Benchmarks
Current Ratio, Competitors2
Abbott Laboratories 1.62 2.26 4.02 1.54 1.45
AbbVie Inc. 0.98 1.28 1.65 1.50 1.41
Allergan PLC 1.13 1.16 2.27 1.03 1.37
Amgen Inc. 2.79 5.49 4.11 4.44 4.95
Biogen Inc. 2.32 2.34 2.55 2.60 2.11
Bristol-Myers Squibb Co. 1.61 1.55 1.55 1.30 1.73
Celgene Corp. 2.23 4.99 3.67 4.77 4.60
Eli Lilly & Co. 1.73 1.32 1.37 1.53 1.09
Gilead Sciences Inc. 3.38 2.74 2.22 2.50 3.07
Merck & Co. Inc. 1.17 1.33 1.78 1.55 1.77
Pfizer Inc. 1.57 1.35 1.25 1.49 2.67
Regeneron Pharmaceuticals Inc. 4.47 3.82 2.56 3.59 3.31
Current Ratio, Sector
Pharmaceuticals & Biotechnology 1.70 1.82 2.14 1.92 2.19
Current Ratio, Industry
Health Care 1.52 1.64 1.83 1.73 1.98

Based on: 10-K (filing date: 2019-02-20), 10-K (filing date: 2018-02-21), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-24).

1 2018 Calculation
Current ratio = Current assets ÷ Current liabilities
= 46,033 ÷ 31,230 = 1.47

2 Click competitor name to see calculations.

Ratio Description The company
Current ratio A liquidity ratio calculated as current assets divided by current liabilities. Johnson & Johnson’s current ratio deteriorated from 2016 to 2017 but then slightly improved from 2017 to 2018.

Quick Ratio

Johnson & Johnson, quick ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 30, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 28, 2014
Selected Financial Data (USD $ in millions)
Cash and cash equivalents 18,107  17,824  18,972  13,732  14,523 
Marketable securities 1,580  472  22,935  24,644  18,566 
Accounts receivable trade, less allowances for doubtful accounts 14,098  13,490  11,699  10,734  10,985 
Total quick assets 33,785  31,786  53,606  49,110  44,074 
 
Current liabilities 31,230  30,537  26,287  27,747  25,085 
Ratio
Quick ratio1 1.08 1.04 2.04 1.77 1.76
Benchmarks
Quick Ratio, Competitors2
Abbott Laboratories 1.03 1.67 3.31 1.04 0.76
AbbVie Inc. 0.78 0.89 1.14 1.21 1.06
Allergan PLC 0.83 0.95 2.00 0.42 0.52
Amgen Inc. 2.44 4.98 3.68 3.97 4.22
Biogen Inc. 1.83 1.78 1.94 1.93 1.54
Bristol-Myers Squibb Co. 1.37 1.30 1.27 1.05 1.26
Celgene Corp. 2.00 4.67 3.24 4.05 4.13
Eli Lilly & Co. 1.20 0.91 0.98 1.04 0.77
Gilead Sciences Inc. 3.15 2.52 1.78 2.07 2.56
Merck & Co. Inc. 0.72 0.83 1.24 1.04 1.19
Pfizer Inc. 0.84 0.93 0.84 1.07 2.07
Regeneron Pharmaceuticals Inc. 3.50 2.98 2.13 3.10 2.93
Quick Ratio, Sector
Pharmaceuticals & Biotechnology 1.27 1.42 1.69 1.48 1.63
Quick Ratio, Industry
Health Care 1.13 1.29 1.44 1.33 1.48

Based on: 10-K (filing date: 2019-02-20), 10-K (filing date: 2018-02-21), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-24).

1 2018 Calculation
Quick ratio = Total quick assets ÷ Current liabilities
= 33,785 ÷ 31,230 = 1.08

2 Click competitor name to see calculations.

Ratio Description The company
Quick ratio A liquidity ratio calculated as (cash plus short-term marketable investments plus receivables) divided by current liabilities. Johnson & Johnson’s quick ratio deteriorated from 2016 to 2017 but then slightly improved from 2017 to 2018.

Cash Ratio

Johnson & Johnson, cash ratio calculation, comparison to benchmarks

Microsoft Excel LibreOffice Calc
Dec 30, 2018 Dec 31, 2017 Dec 31, 2016 Dec 31, 2015 Dec 28, 2014
Selected Financial Data (USD $ in millions)
Cash and cash equivalents 18,107  17,824  18,972  13,732  14,523 
Marketable securities 1,580  472  22,935  24,644  18,566 
Total cash assets 19,687  18,296  41,907  38,376  33,089 
 
Current liabilities 31,230  30,537  26,287  27,747  25,085 
Ratio
Cash ratio1 0.63 0.60 1.59 1.38 1.32
Benchmarks
Cash Ratio, Competitors2
Abbott Laboratories 0.45 1.08 2.82 0.67 0.42
AbbVie Inc. 0.47 0.59 0.66 0.77 0.73
Allergan PLC 0.33 0.65 1.68 0.13 0.05
Amgen Inc. 2.17 4.62 3.40 3.62 3.86
Biogen Inc. 1.07 1.10 1.43 1.33 0.83
Bristol-Myers Squibb Co. 0.83 0.71 0.72 0.53 0.88
Celgene Corp. 1.49 4.03 2.69 3.33 3.57
Eli Lilly & Co. 0.68 0.55 0.55 0.54 0.43
Gilead Sciences Inc. 2.84 2.19 1.29 1.48 1.76
Merck & Co. Inc. 0.40 0.46 0.83 0.70 0.84
Pfizer Inc. 0.59 0.66 0.57 0.79 1.67
Regeneron Pharmaceuticals Inc. 1.95 1.24 0.84 1.29 1.38
Cash Ratio, Sector
Pharmaceuticals & Biotechnology 0.87 1.03 1.29 1.08 1.21
Cash Ratio, Industry
Health Care 0.73 0.90 1.03 0.94 1.07

Based on: 10-K (filing date: 2019-02-20), 10-K (filing date: 2018-02-21), 10-K (filing date: 2017-02-27), 10-K (filing date: 2016-02-24), 10-K (filing date: 2015-02-24).

1 2018 Calculation
Cash ratio = Total cash assets ÷ Current liabilities
= 19,687 ÷ 31,230 = 0.63

2 Click competitor name to see calculations.

Ratio Description The company
Cash ratio A liquidity ratio calculated as (cash plus short-term marketable investments) divided by current liabilities. Johnson & Johnson’s cash ratio deteriorated from 2016 to 2017 but then slightly improved from 2017 to 2018.